Matthew Figley

Matthew Figley is a Senior Scientist in the Discovery Biology department at Vigil Neuro. Matthew was previously a postdoctoral research scholar at Washington University in St. Louis and a Ph.D. candidate at Stanford University School of Medicine.

Figley's research focuses on the molecular mechanisms of neurodegenerative diseases. Their work has helped to define the activation mechanism of the axon pro-degenerative protein SARM1. Matthew has also studied the role of the gene PFN1 in ALS pathogenesis.

Figley received their Ph.D. from Stanford University in 2015 and their postdoctoral training at Washington University in St. Louis in 2021.

Matthew Figley earned a Bachelor of Science in Neuroscience & Theirtory and Philosophy of Science from the University of Pittsburgh. Matthew then went on to earn a Doctor of Philosophy in Neuroscience from Stanford University. Finally, they completed a postdoctoral fellowship in Neuroscience at the University of Pennsylvania.

Matthew Figley reports to Berkley Lynch, VP, Biology. They are on a team with Daria Tchessalova - Senior Scientist II, Discovery Biology, Abigail Renoux - Senior Scientist II, Discovery Biology, and Kelley Larson - Director, Discovery Biology.